flurbiprofen and dezocine

flurbiprofen has been researched along with dezocine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Jiao, L; Liu, RC1
Chen, B; Chong, W; Hai, Y; Lin, L; Liu, F; Liu, L; Pu, Q; Zhou, J1

Trials

2 trial(s) available for flurbiprofen and dezocine

ArticleYear
[Effects of dezocine on postoperative sore throat after maxillofacial procedures: a comparison with flurbiprofen axetil].
    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2014, Feb-18, Volume: 46, Issue:1

    Topics: Adult; Bridged Bicyclo Compounds, Heterocyclic; Double-Blind Method; Flurbiprofen; Humans; Oral Surgical Procedures; Pain Measurement; Pharyngitis; Postoperative Period; Tetrahydronaphthalenes

2014
Effect of patient-controlled intravenous analgesia combined with flurbiprofen axetil and dezocine on postoperative analgesia for lobectomy (EPIC-FAD): a trial protocol.
    Trials, 2021, Mar-01, Volume: 22, Issue:1

    Topics: Analgesia, Patient-Controlled; Analgesics, Opioid; Bridged Bicyclo Compounds, Heterocyclic; Double-Blind Method; Flavin-Adenine Dinucleotide; Flurbiprofen; Humans; Pain, Postoperative; Randomized Controlled Trials as Topic; Tetrahydronaphthalenes

2021

Other Studies

1 other study(ies) available for flurbiprofen and dezocine

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004